You are currently viewing a new version of our website. To view the old version click .

Topic Information

Dear Colleagues,

In order to meet the increased bioenergetic and the mitigate oxidative stress, cancer cells autonomously alter multiple metabolic pathways. The aberrantly accumulation of metabolites could also promote tumorigenesis. The closely relationship between tumor progression and metabolic reprogramming prompt us to uncover new mechanisms regarding metabolic pathways involved in supporting tumor growth and survival. Recent advances in the development of metabolic oncology inhibitors are providing novel approaches for combating cancer. This Topic aims to highlight the latest advances in novel, promising therapeutic approaches and methods of drug delivery targeting tumor metabolism at basic, translational and clinical levels. Original research papers and review articles are welcomed.

Prof. Dr. Qiongzhu Dong
Prof. Dr. Ning Ren
Dr. Chunxiao Liu
Topic Editors

Keywords

  • cancer metabolism
  • tumor microenvironment
  • targeting metabolism
  • cancer therapy resistance
  • mechanism
  • precision medicine
  • inhibitors
  • biomarker

Participating Journals

Cancers
Open Access
33,955 Articles
Launched in 2009
4.4Impact Factor
8.8CiteScore
20 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Future Pharmacology
Open Access
222 Articles
Launched in 2021
2.7Impact Factor
-CiteScore
22 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Journal of Clinical Medicine
Open Access
44,523 Articles
Launched in 2012
2.9Impact Factor
5.2CiteScore
18 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Pharmaceutics
Open Access
13,468 Articles
Launched in 2009
5.5Impact Factor
10.0CiteScore
15 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking

Published Papers